Comparison Chart ADC Therapeutics SA

Stocks

ADCT

CH0499880968

Biotechnology & Medical Research

Market Closed - NYSE 21:00:03 20/10/2026 BST			5-day change	1st Jan Change
1.520 ^USD	+5.56%		-10.59%	-56.94%

10-09	ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says	MT
10-08	ADC Therapeutics SA announced that it expects to receive $81.81 million in funding from Redmile Group, LLC, TCG Crossover Management, LLC, Nantahala Capital Management, LLC, Bain Capital Life Sciences Investors, LLC	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	ADC THERAPEUTICS SA	Bio Therapeutic Drugs	+5.56%	-10.59%	-56.94%	-64.57%	-94.03%	194M